Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A specific chromosomal abnormality in rhabdomyosarcoma.

E C Douglass1, M Valentine, E Etcubanas

  • 1Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38101.

Cytogenetics and Cell Genetics
|January 1, 1987
PubMed
Summary

A specific chromosomal translocation, t(2;13), is a key genetic marker in advanced rhabdomyosarcoma. This finding helps identify the specific cancer type and may guide future research into its origins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electron correlation effects on the femtosecond dephasing dynamics of E22 excitons in (6,5) carbon nanotubes.

The journal of physical chemistry. A·2011
Same author

Exciton dynamics in semiconducting carbon nanotubes.

The journal of physical chemistry. B·2010
Same author

Crystal line aldolase and its identity with myogen A.

Federation proceedings·2010
Same author

The vascular action of beta-dimethylaminoethyl benzhydryl etherhydrochloride (benadryl).

Federation proceedings·2010
Same author

Determination of halogenated hydrocarbons in air.

Bulletin of the U.S. Army Medical Department. United States. Army. Medical Department·2010
Same author

Phonon-assisted electroluminescence from metallic carbon nanotubes and graphene.

Nano letters·2010

Area of Science:

  • Cytogenetics
  • Oncology
  • Molecular Biology

Background:

  • Rhabdomyosarcoma is a pediatric soft tissue sarcoma with diverse histologic subtypes.
  • Understanding the specific genetic alterations in rhabdomyosarcoma is crucial for diagnosis and treatment.
  • Previous research has identified various chromosomal abnormalities in cancer, but specific markers for rhabdomyosarcoma require further elucidation.

Purpose of the Study:

  • To identify specific chromosomal abnormalities in advanced rhabdomyosarcoma.
  • To determine the prevalence and specificity of the t(2;13) translocation in rhabdomyosarcoma.
  • To explore the potential diagnostic and etiological significance of observed cytogenetic findings.

Main Methods:

  • Karyotypic analysis of tumor cells from five advanced rhabdomyosarcoma cases.

Related Experiment Videos

  • Examination of metastatic cells and xenografts.
  • Comparative analysis with over 100 other pediatric solid tumors.

    • Main Results:

    • The specific chromosomal abnormality t(2;13)(q35;q14) was identified in all five studied cases of advanced rhabdomyosarcoma.
    • This translocation was found in metastatic cells and xenografts, irrespective of histologic subtype (alveolar, undifferentiated, embryonal).
    • Other abnormalities included gene amplification markers (double minutes, homogeneously staining regions), chromosome 1p rearrangements, and trisomy 8. The t(2;13) was absent in other pediatric solid tumors.

    Conclusions:

    • The t(2;13) chromosomal translocation is a highly specific cytogenetic marker for rhabdomyosarcoma.
    • This finding provides a basis for further molecular investigations into the pathogenesis of rhabdomyosarcoma.
    • The specificity of t(2;13) may aid in the differential diagnosis of pediatric solid tumors.